1. A journey to vasculopathy in systemic sclerosis: focus on haemostasis and thrombosis

   • Francesco Marongiu
   • Maria Filomena Ruberto
   • Doris Barcellona

   Review 01 November 2023 Pages: 4057 - 4064

   

2. MicroRNA as a potential biomarker for systemic lupus erythematosus: pathogenesis and targeted therapy

   • Urshila Naithani
   • Priyanjal Jain
   • Reema Gabrani

   Review 03 November 2023 Pages: 4065 - 4077

   

3. Behçet’s syndrome: recent advances to aid diagnosis

   • Tayfun Hilmi Akbaba
   • Mustafa Ekici
   • Banu Balci-Peynircioglu

   Review 28 October 2023 Pages: 4079 - 4090

   

4. Clinical advances in immunotherapy for immune-mediated glomerular diseases

   • Bihui Tang
   • Xiao Yang

   Review Open access 27 October 2023 Pages: 4091 - 4105

   

5. Recent advances in the role of neutrophils and neutrophil extracellular traps in acute pancreatitis

   • Hassan Mubarak Ishqi
   • Misha Ali
   • Rajinder Dawra

   Review 19 September 2023 Pages: 4107 - 4122

   

6. Is there a correlation between antibiotic use and the severity or post-infection conditions of COVID-19 and other viral infections?

   • Tsz Yuen Au
   • Chanika Assavarittirong
   • Oskar Wojciech Wiśniewski

   Review 31 August 2023 Pages: 4123 - 4128

7. Serum thymic stromal lymphopoietin (TSLP) levels in atopic dermatitis patients: a systematic review and meta-analysis

   • Marlenne Marisol García-Reyes
   • Luis Carlos Zumaya-Pérez
   • Mario Adán Moreno-Eutimio

   Review Open access 29 July 2023 Pages: 4129 - 4139

   

8. Whole blood hydroxychloroquine: Does genetic polymorphism of cytochrome P450 enzymes have a role?

   • Njundu Jatta
   • Johnson Stanslas
   • Kang Nien How

   Review 22 July 2023 Pages: 4141 - 4152

   

9. Clinical research progress of novel biologics for the treatment of lupus nephritis

   • Wenyan Cui
   • Yunfei Tian
   • Xiuju Liu

   Review 22 July 2023 Pages: 4153 - 4162

10. Killing two birds with one stone: CRISPR/Cas9 CCR5 knockout hematopoietic stem cells transplantation to treat patients with HIV infection and hematological malignancies concurrently

    • Tsz Yuen Au
    • Jayshen Arudkumar
    • Shamiram Benjamin

    Review 27 July 2023 Pages: 4163 - 4175

    

11. An update on mechanisms of pruritus and their potential treatment in primary cutaneous T-cell lymphoma

    • Man Hu
    • Jörg Scheffel
    • Martin Metz

    Review Open access 09 August 2023 Pages: 4177 - 4197

    

12. Management of classical Philadelphia chromosome-negative myeloproliferative neoplasms in Asia: consensus of the Asian Myeloid Working Group

    • Harinder Gill
    • Garret M. K. Leung
    • Yok-Lam Kwong

    Review 25 September 2023 Pages: 4199 - 4217

    

13. Advances in the pathogenesis and therapeutic strategies of angioimmunoblastic T-cell lymphoma

    • Qingyang Zhang
    • Le Yin
    • Hongling Peng

    Review 27 September 2023 Pages: 4219 - 4235

    

14. Evaluation of Bruton tyrosine kinase inhibitors monotherapy and combination therapy in lymphocytic leukemia

    • Xiangxing Liu
    • Binyi Hu
    • Yi Fang

    Review 13 October 2023 Pages: 4237 - 4248

    

15. Correction to: Evaluation of Bruton tyrosine kinase inhibitors monotherapy and combination therapy in lymphocytic leukemia

    • Xiangxing Liu
    • Binyi Hu
    • Yi Fang

    Correction 02 December 2023 Pages: 4249 - 4249

16. Real-life diagnostic and therapeutic approach to CLL: a 2022 update from an expert panel in Tuscany

    • Claudia Baratè
    • Alessandro Sanna
    • Alessandro Gozzetti

    Review 18 November 2023 Pages: 4251 - 4264

17. EMT-induced immune evasion: connecting the dots from mechanisms to therapy

    • Sikiru O. Imodoye
    • Kamoru A. Adedokun

    Review 15 November 2023 Pages: 4265 - 4287

    

18. Genetic alterations shape innate immune cells to foster immunosuppression and cancer immunotherapy resistance

    • Louis Boafo Kwantwi

    Review 01 November 2023 Pages: 4289 - 4296

19. Immune checkpoint targeting antibodies hold promise for combinatorial cancer therapeutics

    • Ritu
    • Prakash Chandra
    • Asmita Das

    Review 07 October 2023 Pages: 4297 - 4322

    

20. Interplay between signal transducers and activators of transcription (STAT) proteins and cancer: involvement, therapeutic and prognostic perspective

    • Nandana Jill
    • Sannidhi Bhootra
    • Koustav Sarkar

    Review 29 September 2023 Pages: 4323 - 4339

    

21. Clinicopathological features and prognostic significance of pulmonary adenocarcinoma with signet ring cell components: meta-analysis and SEER analysis

    • Yang Tan
    • Ying-he Huang
    • Zhen-Bo Feng

    Review 01 October 2023 Pages: 4341 - 4354

    

22. Effect of aspirin, warfarin, and proton-pump inhibitors on performance of fecal immunochemical test in colorectal cancer screening: a systematic review and meta-analysis

    • Zhongxue Han
    • Xueping Nan
    • Yueyue Li

    Review 07 October 2023 Pages: 4355 - 4368

    

23. Prognostic value of primary tumor location in colorectal cancer: an updated meta-analysis

    • Hanieh Gholamalizadeh
    • Nima Zafari
    • Amir Avan

    Review 05 July 2023 Pages: 4369 - 4383

    

24. Circulating tumor cells in gastric cancer: developments and clinical applications

    • Qian Deng
    • Bo Jiang
    • Zhenzhen Cao

    Review 07 August 2023 Pages: 4385 - 4399

    

25. Role of long pentraxin PTX3 in cancer

    • Duo Li
    • Zhaozhao Hao
    • Yanwei Chen

    Review 12 July 2023 Pages: 4401 - 4411

    

26. CXCL6: A potential therapeutic target for inflammation and cancer

    • Chun-Lan Dai
    • Hong-Xuan Yang
    • Hong Zhang

    Review 23 August 2023 Pages: 4413 - 4427

    

27. Correction to: CXCL6: A potential therapeutic target for inflammation and cancer

    • Chun-Lan Dai
    • Hong-Xuan Yang
    • Hong Zhang

    Correction 26 October 2023 Pages: 4429 - 4429

28. Breast cancer immunotherapy: a comprehensive review

    • Samaneh Keshavarz
    • Jack R. Wall
    • Reza Jafari-Shakib

    Review 01 September 2023 Pages: 4431 - 4447

    

29. RETRACTED ARTICLE: Angiopoietin4 (ANGPT4) expression and potential mechanisms in carcinogenesis: current achievements and perspectives

    • Wen-chao Zhou
    • Qun-feng Zhang
    • Juan Zou

    Review 02 September 2023 Pages: 4449 - 4456

    

30. LncRNA MALAT1 signaling pathway and clinical applications in overcome on cancers metastasis

    • Madineh Mazarei
    • Venus Shahabi Rabori
    • Mohammadreza Saberiyan

    Review 11 September 2023 Pages: 4457 - 4472

    

31. Clinical implications of myeloid malignancy‑related somatic mutations in aplastic anemia

    • Lingling Liu
    • Danfeng Zhang
    • Yingmei Li

    Research Open access 22 April 2023 Pages: 4473 - 4482

    

32. Expression and prognostic value of C-reactive protein in adult immune thrombocytopenia (ITP) patients

    • YaNan Zhang
    • FengAn Liu
    • Hai Cheng

    Research 28 March 2023 Pages: 4483 - 4491

    

33. DNA methylation of hematopoietic stem/progenitor cells from donor peripheral blood to patient bone marrow: implications for allogeneic hematopoietic stem cell transplantation

    • Ilaria Laurenzana
    • Luciana De Luca
    • Stefania Trino

    Research Open access 07 April 2023 Pages: 4493 - 4510

    

34. Multiparametric analysis of etoposide exposed mesenchymal stem cells and Fanconi anemia cells: implications in development of secondary myeloid malignancy

    • Cansu Özdemir
    • Bihter Muratoğlu
    • Duygu Uçkan-Çetinkaya

    Research 13 May 2023 Pages: 4511 - 4524

    

35. Correction to: Multiparametric analysis of etoposide exposed mesenchymal stem cells and Fanconi anemia cells: implications in development of secondary myeloid malignancy

    • Cansu Özdemir
    • Bihter Muratoğlu
    • Duygu Uçkan-Çetinkaya

    Correction 09 September 2023 Pages: 4525 - 4525

36. Immune-related lncRNAs pairs prognostic score model for prediction of survival in acute myeloid leukemia patients

    • Xue Liang
    • Cong Li
    • Zhimin Zhai

    Research Open access 26 May 2023 Pages: 4527 - 4538

    

37. Identification and validation of the optimal reference genes for standardizing the gene expression profiling diagnostic panel of Ph-like B-lineage acute lymphoblastic leukemia

    • Dikshat Gopal Gupta
    • Neelam Varma
    • Subhash Varma

    Research 20 July 2023 Pages: 4539 - 4551

    

38. Identifying prognostic biomarker related to immune infiltration in acute myeloid leukemia

    • Weixiang Lu
    • Guopan Yu
    • Dan Xu

    Research 10 August 2023 Pages: 4553 - 4562

    

39. Bloodstream infections in neutropenic and non-neutropenic patients with haematological malignancies: epidemiological trends and clinical outcomes in Queensland, Australia over the last 20 years

    • Anna Maria Peri
    • Felicity Edwards
    • Kevin B. Laupland

    Research Open access 10 October 2023 Pages: 4563 - 4573

    

40. Subcutaneous panniculitis-like T-cell lymphoma associated with hemophagocytic lymphohistiocytosis: a systematic review of 63 patients reported in the literature

    • Wenxin Ou
    • Yunze Zhao
    • Rui Zhang

    Research 16 October 2023 Pages: 4575 - 4583

    

41. Causal relationships between circulating inflammatory cytokines and diffuse large B cell lymphoma: a bidirectional Mendelian randomization study

    • Jieni Yu
    • Leihua Fu
    • Chao Xu

    Research 01 November 2023 Pages: 4585 - 4595

    

42. Albumin-to-fibrinogen ratio is an independent prognostic parameter in de novo non-M3 acute myeloid leukemia

    • Yaqun Ding
    • Xiangyu Qi
    • Shuangnian Xu

    Research 01 November 2023 Pages: 4597 - 4608

    

43. Efficacy and safety of Orelabrutinib-based regimens in diffuse large B-cell lymphoma: a single-center retrospective analysis

    • Ruowen Wei
    • Yingying Wu
    • Jun Fang

    Research Open access 04 November 2023 Pages: 4609 - 4621

    

44. Cytokine levels in patients with non-M3 myeloid leukemia are key indicators of how well the disease responds to chemotherapy

    • Rui Hu
    • Xiaosui Ling
    • Yunyun Du

    Research 04 November 2023 Pages: 4623 - 4632

    

45. Reduced regulatory effects of bone marrow-derived mesenchymal stem cells on activated T lymphocytes and Th1/Th2 cytokine secretion in children with aplastic anemia

    • Xiaoping Guo
    • Wenwen Weng
    • Yongmin Tang

    Research 06 November 2023 Pages: 4633 - 4646

    

46. Correction to: Reduced regulatory effects of bone marrow-derived mesenchymal stem cells on activated T lymphocytes and Th1/Th2 cytokine secretion in children with aplastic anemia

    • Xiaoping Guo
    • Wenwen Weng
    • Yongmin Tang

    Correction 06 December 2023 Pages: 4647 - 4647

47. CircZBTB46 predicts poor prognosis and promotes disease progression of myelodysplastic syndromes and acute myeloid leukemia

    • Shuang Li
    • Guangjie Zhao
    • Xiaoqin Wang

    Research 06 November 2023 Pages: 4649 - 4664

    

48. Prognostic impact of absolute peripheral blood NK cell count after four cycles of R-CHOP-like regimen treatment in patients with diffuse large B cell lymphoma

    • Zhongjun Huo
    • Fang Chen
    • Zimian Luo

    Research Open access 08 November 2023 Pages: 4665 - 4672

    

49. Clinical and imaging features of lymphomatosis cerebri: analysis of 8 cases and systematic review of the literature

    • Mengke Fan
    • Lu Zhao
    • Yunfei Song

    Research Open access 18 November 2023 Pages: 4673 - 4680

    

50. Causal inference between rheumatoid arthritis and prostate cancer

    • Junyong Ou
    • Lang Zou
    • Cheng Liu

    Research 11 August 2023 Pages: 4681 - 4694